GlassScriptPhysician profile
Alan J Acierno
NPI 1235200627
$2,410.31
in general payments reported to CMS, 2019-2025
12 companies · $549 in 2025
The $549 reported for 2025 was more than what 91% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $22.72 · 2021: $123 · 2022: $75.29 · 2023: $512 · 2024: $847 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490 · Travel and Lodging: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.58 |
| Travel and Lodging | $418.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,140.27 | 2019-2025 | Opalescence |
| Henry Schein, INC. | $688.35 | 2019-2025 | Dentrix Ascend Imaging, Reveal Aligners, Henry Schein |
| Ortho Organizers, INC. | $159.30 | 2023 | Reveal Aligners |
| Envista Holdings Corporation | $104.50 | 2024 | Tf Adaptive, Zirconia Abutment Preparation Kit |
| Align Technology, INC. | $95.27 | 2019-2024 | Invisalign |
| USA Angelalign Technology Corp | $77.69 | 2024-2025 | |
| Implant Direct Sybron International LLC | $30.03 | 2019 | |
| Gc America INC. | $26.32 | 2020-2022 | |
| Ormco Corporation | $24.92 | 2023 | Nomad Pro 2 |
| Nobel Biocare USA | $24.92 | 2023 | Nobelactive |
| Dexcel Pharma Technologies LTD. | $22.74 | 2019-2021 | |
| Patterson Companies, INC. | $16.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Acierno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.